CVE-2026-100584
OpenClaw is an npm-distributed agent runtime. In versions >= 2026.2.26 and < 2026.7.1, PowerShell command analysis on Windows hosts running in exec allowlist mode could approve an exact executable resolved from PATH but subsequently execute a same-named executable located in the workspace directory. If lower-trust content can place an executable with an approved basename into an agent-writable workspace and steer an approved PowerShell command that uses a bare executable name, OpenClaw may run the workspace file instead of the allowlisted path, executing arbitrary code with the privileges of the Gateway or node-host user. The issue does not require replacement of the approved executable itself. Version 2026.7.1 contains a fix; as a workaround, avoid bare executable names in approved PowerShell commands and keep executable files out of agent-writable workspaces.
Executive briefing
A structured intelligence assessment has not yet been generated. The source description is shown above. The background enrichment worker will retry this record.
Evidence confidence: Not assessed Evidence-derived, not an exploitability verdict
Severity & attack characteristics
CVSS vector:Not supplied
No CVSS vector is currently available in the source record.
Technical explanation & impact
Technical root-cause details are not available in the current source record.
Assess the impact using the published CVSS metrics and the affected vendor component.
Affected products and versions
NVD has not supplied machine-readable vulnerable CPE product/version entries for this CVE. This is an information gap, not proof that no products are affected. Check the vendor advisory references below.
Remediation & validation
- Identify exposure by comparing the affected product and version ranges with your asset inventory, SBOM and externally exposed services.
- Review the linked vendor security advisory or patch notes. Upgrade to a vendor-confirmed fixed release; do not infer a fixed version from the CVE description.
- Until patched, consider restricting network access or disabling the affected feature where operationally safe. These are temporary controls, not a substitute for a vendor fix.
- Validate the remediation with a version check and vulnerability rescan, then retain change evidence.
No fixed version is displayed unless it is explicitly established by a vendor advisory. Follow the vendor's release notes for exact product and branch applicability.
Vendor advisories, patches & exploit references
No external references are currently supplied in the CVE record.